Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemia.

Saved in:
Bibliographic Details
Title: Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemia.
Authors: Contreras CF; Children's Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, Philadelphia, Pennsylvania., Higham CS; San Francisco Benioff Children's Hospital and School of Medicine, Pediatrics, Division of Pediatric Bone Marrow Transplantation, University of California, San Francisco, California., Behnert A; San Francisco Benioff Children's Hospital and School of Medicine, Pediatrics, Division of Hematology-Oncology, University of California, San Francisco, California., Kim K; Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania., Stieglitz E; San Francisco Benioff Children's Hospital and School of Medicine, Pediatrics, Division of Hematology-Oncology, University of California, San Francisco, California., Tasian SK; Children's Hospital of Philadelphia, Division of Oncology and Center for Childhood Cancer Research, Philadelphia, Pennsylvania.; Department of Pediatrics and Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2021 Jan; Vol. 68 (1), pp. e28718. Date of Electronic Publication: 2020 Oct 24.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1545-5017
DOI:10.1002/pbc.28718